“…American cutaneous leishmaniasis (ACL) presents distinct active clinical forms with different grades of severity, known as localised (LCL), intermediate (ICL) and diffuse (DCL) cutaneous leishmaniasis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…After immunosuppressive therapy, reactivation of cutaneous leishmaniasis with the above presentation took place. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Leishmaniasis is increasingly reported among travellers. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Cutaneous leishmaniasis (CL) is the most frequent clinical form of tegumentary leishmaniasis and is characterised by a single or a few ulcerated skin lesions that may disseminate into multiple ulcers and papules, which characterise disseminated leishmaniasis (DL). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Leishmaniasis is a pestilent affliction that importunately needs better therapeutics necessitated by the absence of effective vaccine, emergence as HIV co-infection, and the dread of debilitating chemotherapy. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In tegumentary leishmaniasis caused by Leishmania braziliensis, there is evidence that increased production of IFN-γ, TNF-α and absence of IL-10 is associated with strong inflammatory reaction and with tissue destruction and development of the lesions observed in cutaneous leishmaniasis (CL) and mucosal leishmaniasis (ML). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Visceral leishmaniasis (VL) or kala-azar, a vector-borne protozoan disease, shows endemicity in larger areas of the tropical, subtropical and the Mediterranean countries. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…We present an interesting case report of two sarcoid-like lesions on a port-wine stain (PWS) birthmark in a Brazilian patient which on investigation proved to be cutaneous leishmaniasis.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Visceral Leishmaniasis (VL), a systemic infection of the reticuloendotherlial system, is caused by a parasitic infection. …”
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Cutaneous leishmaniasis (CL) is one of the common tropical protozoal diseases caused by various Leishmania species, and transmitted by the sand-fly vectors, Phlebotomus and Lutzomyia species. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Leishmaniasis, caused by infection with parasites of the Leishmania genus, affects millions of individuals worldwide. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Nevertheless, there are few studies investigating the effect of vitamin A in visceral leishmaniasis (VL), although there are reports of its deficiency in children with symptomatic VL in Brazil and Bangladesh. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Cutaneous Leishmaniasis (CL) is a neglected tropical vector-borne disease. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

Enlace del recurso
Enlace del recurso
Enlace del recurso

“…INTRODUCTION: Studies employing serological, DTH or conventional PCR techniques suggest a vast proportion of Leishmania infected individuals living in regions endemic for Visceral Leishmaniasis (VL) remain asymptomatic. This study was designed to assess whether quantitative PCR (qPCR) can be used for detection of asymptomatic or early Leishmania donovani infection and as a predictor of progression to symptomatic disease. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Visceral leishmaniasis (VL) is a severe disease caused by Leishmania infantum in the Mediterranean basin, and is associated with considerable morbidity and mortality. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Leishmaniasis is an infectious disease that is endemic in tropical areas and in the Mediterranean. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Long regimens for the treatment of post-kala-azar dermal leishmaniasis (PKDL) result in noncompliance. A safe, effective, and acceptable regimen for the treatment of PKDL is still to be developed. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Cutaneous leishmaniasis is an annoying and disfiguring disease affecting around 1,500,000 individuals globally. …”
Enlace del recurso
Enlace del recurso

“…He was diagnosed as a case of post kala azar dermal leishmaniasis, managed with injection sodium stibogluconate and followed-up thereafter.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso